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Objective: To clarify the association between the occurrence and progression of knee osteoarthritis (KOA)
with components of metabolic syndrome (MS), including overweight (OW), hypertension (HT), dysli-
pidaemia (DL), and impaired glucose tolerance (IGT), in a general population.
Design: From the large-scale population-based cohort study entitled Research on Osteoarthritis/Osteo-
porosis Against Disability (ROAD) initiated in 2005, 1,690 participants (596 men, 1,094 women) residing
in mountainous and coastal areas were enrolled. Of these, 1,384 individuals (81.9%; 466 men, 918
women) completed the second survey, including knee radiography, 3 years later. KOA was deﬁned as
KellgreneLawrence (KL) grade  2 using paired X-ray ﬁlms. Based on changes in KL grades between the
baseline and second surveys, cumulative incidence and progression of KOAwere determined. OW, HT, DL,
and IGT at baseline were assessed using standard criteria.
Results: The cumulative incidence of KOA among 1,384 completers over 3 years was 3.3%/year, and
progression in KL grades for either knee, 8.0%/year. Logistic regression analyses after adjusting for
potential risk factors revealed that the odds ratio (OR) for the occurrence of KOA signiﬁcantly increased
according to the number of MS components present (OR vs no component: one component, 2.33; two
components, 2.82; three components, 9.83). Similarly, progression of KOA signiﬁcantly increased
according to the number of MS components present (OR vs no component: one component, 1.38; two
components, 2.29; three components: 2.80).
Conclusion: Accumulation of MS components is signiﬁcantly related to both occurrence and progression
of KOA. MS prevention may be useful in reducing future KOA risk.
 2012 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Osteoarthritis (OA), which causes cartilage and disc degenera-
tion and osteophyte formation at joints in the limbs and spine, is
a major public health problem in the elderly and affects activities of
daily living and quality of life, leading to increased morbidity and
mortality1e3. According to the recent National Livelihood Survey byN. Yoshimura, Department of
arch Center, Graduate School
Bunkyo-ku, Tokyo 113-8655,
p (N. Yoshimura).
s Research Society International. Pthe Ministry of Health, Labour and Welfare in Japan, OA is ranked
fourth among diseases that cause disabilities requiring support and
long-term care4. The National Livelihood Survey also shows that
cardiovascular disease (CVD) is ranked ﬁrst in causing disabilities in
the elderly4. Most CVD patients have multiple risk factors5. The
presence of these risk factors in a speciﬁc combination, entitled
metabolic syndrome (MS), is a multiplex risk factor that predis-
poses affected individuals to CVD morbidity and mortality. MS is
generally considered a combination of being overweight (OW) and
having hypertension (HT), dyslipidaemia (DL), and impaired
glucose tolerance (IGT)6.
Knee OA (KOA) and MS share age and obesity as risk
factors1,7e12. Numerous investigators have associated OA withublished by Elsevier Ltd. All rights reserved.
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blood pressure (BP) was associated with KOA in women13. Kellgren
reported that hand OA was signiﬁcantly associated with above-
average serum cholesterol levels in women14. Cimmino et al.
observed signiﬁcantly higher plasma glucose levels in women with
OA than in those without15. Contradictory ﬁndings regarding the
association of such metabolic factors with OA have been
reported16e19. Hart et al. found that metabolic factors such as blood
glucose, hypercholesterolaemia, and even treated HT were associ-
ated with KOA development20. A few population-based studies
have demonstrated a doseeresponse relationship between risk
factor accumulation for MS and KOA; we have previously reported
that KOA presence was signiﬁcantly associated with increase in the
number of MS components21. However, to our knowledge, no study
has clariﬁed the associations between KOA occurrence or
progression and MS component accumulation, using a prospective
cohort of general inhabitants.
This study evaluated the incidence and progression of radio-
graphic KOA and its associations with individual and cumulative
MS components (OW, HT, DL, and IGT) among men and women
using the large-scale, population-based cohort from the Research
on Osteoarthritis/Osteoporosis Against Disability (ROAD) study.
Method
Participants
This study involved the cohorts established in 2005 for the
ROAD study. Details of the cohort proﬁle have been reported else-
where22,23 and are only brieﬂy described here. In 2005e2007, we
created a baseline database including clinical information for 3,040
residents of Japan (men, 1,061; women, 1,979). The subjects were
recruited from resident registration listings in three communities
with different characteristics: 1,350 individuals (men, 465; women,
885) from an urban region in Itabashi, Tokyo; 864 individuals (men,
319; women, 545) from a mountainous region in Hidakagawa,
Wakayama; and 826 individuals (men, 277; women, 549) from
a coastal region in Taiji, Wakayama. In 2008e2010, we attempted to
locate and follow-up all 3,040 subjects. They were invited for the
second survey of the ROAD study, a 3-year follow-up examination
identical to the baseline examinations.
For the current study, we enrolled all 1,690 subjects (men, 596;
women, 1,094) resided in the mountainous and coastal areas,
where blood examination had been performed on all participants at
baseline. All participants provided written informed consent, and
the study was conducted with approval from the ethics committees
of the University of Tokyo.
Baseline examination procedures
At the baseline examination, participants completed an
interviewer-administered questionnaire of 400 items, including
lifestyle information such asprimaryoccupation; smokinghabits (0:
ex- or non-smoker,1: current smoker); alcohol consumption (0: ex-
or non-drinker, 1: current drinker); physical activity, including
bicycling every day over the past 12 months (0: no, 1: yes); regular
exercise (0: no,1: yes); andmedical history, includinghistoryof knee
injuries (0: no, 1: yes). The participants were asked whether they
tookprescriptionmedicationdaily or nearly everyday (0: no,1: yes).
If they did not know what their medications were prescribed for,
they were asked to bring their medications to the medical doctor
(NY).
Anthropometric measurements included height, weight, and
body mass index [BMI: weight (kg)/height2 (m2)]. Systolic and dia-
stolic BPwasmeasured by an experienced public health nurse usinga mercury sphygmomanometer. Medical information, including
information on knee joints, was collected by experienced ortho-
paedic surgeons (SM and HO). All participants underwent radio-
graphic examinationof bothkneesusing ananterioreposterior view
with weight-bearing and foot-map positioning.
All blood samples were obtained between 09:00 and 15:00.
Haemoglobin A1c (HbA1c), blood sugar, high-density lipoprotein
cholesterol (HDL-cho), total cholesterol, and triglyceride (TG) levels
were measured. All analyses were performed at the same labora-
tory within 24 h of extraction (Osaka Kessei Research Laboratories,
Inc., Osaka, Japan).
In this study, deﬁnitions of MS components were based on
criteria deﬁned by the Examination Committee of Criteria for
Metabolic Syndrome in Japan24 and the Japan Society for the Study
of Obesity25. However, because not all blood samples were ob-
tained under fasting conditions, we used indices from the National
Health and Nutrition Survey in Japan adopted as MS criteria in this
national screening study due to the difﬁculty of collecting samples
under fasting conditions26. The following deﬁnitions were used for
MS components: OW, BMI  25 kg/m2; HT, systolic
BP  130 mm Hg and/or diastolic BP  85 mm Hg; DL, serum HDL-
cho level < 40 mg/dL; and IGT, serum HbA1c level  5.5%.
Furthermore, subjects being treated with medication for HT, DL, or
diabetes mellitus were regarded as having HT, DL, or IGT,
respectively.
Three-year follow-up and deﬁnition of KOA occurrence and
progression
In 2008e2010, the 1,690 subjects were invited to attend the
second survey of the ROAD study, a 3-year follow-up consisting of
examinations identical to those at baseline. Knee radiographs were
read by a single experienced orthopaedist (SM) without knowledge
of participants’ clinical status and were categorized using the
KellgreneLawrence (KL) grading scale27. When there were differ-
ences in the KL grades between the two knees, the higher KL grade
was assigned to the participant. A subject with KL  2 was deﬁned
as having radiographic KOA. A new KOA case was identiﬁed if both
knees had a KL grade < 2 at baseline and if at least one knee
developed a KL of 2 during follow-up. KOA progression was
deﬁned as the KL grade for either knee being higher during follow-
up than at baseline.
Statistical analysis
All statistical analyses were performed using STATA statistical
software (STATA Corp., College Station, TX, USA). Differences in
proportions were compared using the chi-square test. Differences
in continuous variables were tested for signiﬁcance using analysis
of variance for multiple groups or Scheffe’s least signiﬁcant differ-
ence test for pairs of groups. All P values and 95% conﬁdence
intervals (CI) are two-sided.
To clarify associations between KOA occurrence or progression
and MS risk factors, we performed three types of multivariate
logistic regression analysis. Model 1 was performed using KOA
occurrence or progression (over 3 years, 1: yes, 0: no) as the
objective variable. Each risk factor for MS, that is, continuous
variables such as BMI, systolic BP, diastolic BP, and serum HDL-cho
and HbA1c levels, and categorical variables such as OW (1: pres-
ence, 0: absence), HT (1: presence, 0: absence), DL (1: presence, 0:
absence), and IGT (1: presence, 0: absence) were considered as an
individual explanatory variable after adjusting for age and gender.
Model 2 was performed using the same objective variable and
individual explanatory factor for MS as inModel 1, after adjustment
for age, gender, regional differences, smoking, alcohol
Table I
Baseline characteristics of subjects who participated in both the ﬁrst and second
surveys
Total Men Women P (men
vs women)
Number of subjects classiﬁed by age-strata (%)
39 (year) 39 (2.8) 10 (2.1) 29 (3.2) 0.23
40e49 135 (9.8) 40 (8.6) 95 (10.3)
50e59 298 (21.5) 99 (21.2) 199 (21.7)
60e69 413 (29.8) 131 (28.1) 282 (30.7)
70e79 404 (29.2) 155 (33.3) 249 (27.1)
80 95 (6.9) 31 (6.7) 64 (7.0)
Total 1384 (100.0) 466 (100.0) 918 (100.0)
Means (standard deviations) of selected characteristics
Age (year) 63.9 (11.8) 64.9 (11.6) 63.4 (11.9) 0.0246*
Height (cm) 155.6 (9.0) 164.0 (7.0) 151.3 (6.7) <0.001***
Weight (kg) 56.0 (10.7) 62.1 (10.7) 52.5 (8.7) <0.001***
Prevalence of selected characteristics, %
Residing in a coastal
area
54.1 51.9 55.2 0.245
Current smoking habit
(more than once a
month)













15.3 36.1 4.7 <0.001***
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injuries, all of which had been found to be signiﬁcantly associated
with KOA presence in a previous study using the same population17.
Model 3 was obtained by multivariate logistic regression analysis
using the same objective variable and the same adjustment factors
as in Model 2; furthermore, other MS components were included in
the mutual adjustment model. For example, when BMI was
selected as an objective factor, Model 3 was obtained by multivar-
iate logistic regression after adjustment for age, gender, regional
differences, smoking, alcohol consumption, bicycling, regular
exercise, history of knee injuries, systolic BP, and serum HDL-cho
and HBA1c levels. Similarly, when OW was selected as an objec-
tive factor, Model 3 was obtained bymultivariate logistic regression
after adjustment for age, gender, regional differences, smoking,
alcohol consumption, bicycling, regular exercise, history of knee
injuries, HT, DL, and IGT. Because systolic and diastolic BP was
moderately correlated (r ¼ 0.5643, P < 0.001), only values of
systolic BP were used as representative of BP in Model 3.
To further evaluate associations between the number of MS
components and KOA occurrence and progression, we used two
multivariate logistic regression models. In Model 4, we used KOA
occurrence or KL grade progression as the objective variable and
the number of MS components present (OW, HT, DL, and IGT) as the
explanatory variable, after adjusting for age and gender. In Model 5,
we used KOA occurrence or progression as the objective variable
and the number of MS components present as the explanatory
variable, after adjusting for age, gender, regional differences,
smoking, alcohol consumption, bicycling, regular exercise, and
history of knee injuries.or golf, after
graduation from
school (%)
Past injury of either
knee (%)
2.5 1.9 2.8 0.313
Medication for components of MS, %
Medication for HT 29.8 27.5 31.1 0.169




5.6 7.3 4.8 0.056
Mean values (standard deviations) for components of MS
BMI (kg/m2) 23.1 (3.4) 23.4 (3.2) 22.9 (3.4) 0.0089
Systolic BP (mm Hg) 134.1 (20.4) 136.6 (18.3) 132.9 (21.4) 0.0015**
Diastolic BP (mm Hg) 74.2 (11.4) 77.0 (11.5) 72.8 (11.0) <0.0001***
Serum levels of
HDL-cho (mg/dL)
61.2 (15.9) 55.8 (16.1) 64.0 (15.0) <0.0001***
Serum levels of
HbA1c (%)
5.19 (0.73) 5.23 (0.85) 5.17 (0.67) 0.1900Results
Eligible participants
Of the 1,690 baseline survey participants, 251 (14.9%; men, 104;
women, 147) dropped out of the follow-up study. The reasons for
the drop-outs are shown in Fig. 1. In this study, we used the data for
the remaining 1,384 subjects (81.9%; men, 466; women, 918) who
completed all examinations in both baseline and follow-up surveys.
Table I shows baseline characteristics of the 1,384 participants
and mean values for BMI, systolic and diastolic BP, and serum HDL-
cho and HbA1c levels, classiﬁed by gender. Men had signiﬁcantly
higher BMI, higher systolic and diastolic BP, and lower serum HDL-
cho levels thanwomen. However, serumHbA1c levels did not show2008-2010 Second visit  
Drop-outs 
Death: 27 men, 13 women 
Illness: 32 men, 65 woman 
Moved away: 5 men, 11 women 
Declined 2nd visit: 24 men,  27
 women 
Absence: 4 men, 4 women 
Other reasons: 12 men, 27
 women 
2005-2007 Baseline study  
1690 individuals
 (596 men, 1096 women)
1384 individuals
 (81.9%; 466 men, 918 women)
Did not complete second visit 
26 men, 29 women  
Incompletes 
Fig. 1. Flow of participants in the baseline and second surveys.
Prevalence of components of MS, %
OW 25.7 28.1 24.4 0.135
HT 67.2 72.7 64.4 0.002**
DL 13.0 15.2 11.9 0.079
IGT 21.1 24.7 19.3 0.020*
*P < 0.05, **P < 0.01, ***P < 0.001.signiﬁcant gender-based differences. In the total population, the
MS component with the highest prevalence was HT, followed by
OW, IGT, and DL. The prevalences of HT and IGT were signiﬁcantly
higher in men than in women.
KOA occurrence and progression and MS components
Baseline KOA prevalence in the 1,384 individuals was 46.8%
(men, 37.3%; women, 51.6%). After exclusion of subjects having KOA
(KL grade  2 in at least one knee) at baseline, the cumulative KOA
incidence during the 3-year follow-up was estimated using a pop-
ulation-at-risk of 728 individuals (men, 290; women, 438) without
N. Yoshimura et al. / Osteoarthritis and Cartilage 20 (2012) 1217e12261220KOA in either knee at baseline. Among these subjects, 71 new KOA
cases (men, 18; women, 53) were detected, with a cumulative
incidence of 3.3%/year (men, 2.1%/year; women, 4.0%/year). After
excluding subjects with KL grade ¼ 4 for at least one knee at
baseline, the progression rate over the 3-year follow-up was esti-
mated using the population-at-risk of 1,296 individuals (men, 445;
women, 851). Among these, 311 individuals (men, 86; women, 225)
had a higher KL grade for one or both knees at follow-up than at
baseline. The progression proportion of the KL grade for either knee
over the 3-year period was 24.0% (8.0%/year; men, 6.4%/year;
women, 8.8%/year) in the overall population-at-risk.
Table II shows cumulative KOA incidence and progression,
classiﬁed by age groups of 39, 40e49, 50e59, 60e69, 70e79, and
80 years, which signiﬁcantly increased with age. BMI, systolic BP,
and HbA1c levels at baselinewere signiﬁcantly higher and HDL-cho
levels signiﬁcantly lower in subjects with KOA than in those
without KOA. Similar to KOA, BMI, systolic BP, and HbA1c levels
were signiﬁcantly higher and HDL-cho levels signiﬁcantly lower in
subjects with KL grade progression than in those without. This
tendency was much more pronounced in women than in men.
Table III shows multivariate logistic regression analysis results
for KOA occurrence vs values for each MS component, including
BMI, systolic BP, diastolic BP, and serum HDL-cho and HbA1c levels
measured at baseline (Table III). Model 2 showed that BMI, systolicTable II
Mean values (standard deviations) for components of MS vs occurrence and progression
Total Men
KOA () KOA (þ) P KOA ()
(n ¼ 657) (n ¼ 71) (n ¼ 272)
Occurrence of KOA
Number of subjects classiﬁed by age-strata (cumulative incidence, %/year)
39 (year) 38 0 (0.0) <0.001 10
40e49 118 1 (0.3) 36
50e59 201 15 (2.3) 77
60e69 177 27 (4.4) 76
70e79 108 23 (5.9) 62
80 15 5 (8.3) 11
Mean values (standard deviations) for age and components of MS
Age (year) 58.2 (11.8) 67.3 (8.2) <0.0001 61.0 (11.8
BMI (kg/m2) 22.4 (3.2) 23.6 (2.9) 0.0035 23.2 (3.2)
Systolic BP (mm Hg) 129.6 (19.4) 138.2 (19.1) 0.0005 133.4 (17.9
Diastolic BP (mm Hg) 74.3 (11.2) 74 (11.0) 0.8599 77.5 (11.8
Serum levels of
HDL-cho (mg/dL)
63.4 (16.8) 59.2 (13.3) 0.0414 57.3 (16.3
Serum levels of HbA1c (%) 5.11 (0.67) 5.32 (0.79) 0.0142 5.24 (0.87
Total Men
Progression () Progression (þ) P Progression
(n ¼ 985) (n ¼ 311) (n ¼ 359)
Progression of KOA
Number of subjects classiﬁed by age-strata (proportion of progression, %/year)
39 (year) 37 2 (1.7) <0.001*** 9
40e49 128 7 (1.7) 38
50e59 248 44 (5.0) 89
60e69 292 105 (8.2) 101
70e79 241 115 (10.8) 105
80 39 38 (16.5) 17
Mean values (standard deviations) for age and components of MS
Age (year) 61.6 (11.9) 68.7 (9.3) <0.0001*** 63.3 (11.8
BMI (kg/m2) 22.7 (3.3) 23.6 (3.1) <0.0001*** 23.2 (3.2)
Systolic BP (mm Hg) 132.2 (20.0) 137.9 (19.3) <0.0001*** 135.4 (17.9
Diastolic BP (mm Hg) 74.0 (11.2) 74.5 (11.8) 0.5517 77.1 (11.6
Serum levels of
HDL-cho (mg/dL)
62.3 (16.6) 59.0 (13.8) 0.0018** 56.7 (16.4
Serum levels of HbA1c (%) 5.15 (0.72) 5.27 (0.74) 0.0133* 5.20 (0.84
KOA(), non-occurrence of KOA; KOA(þ), occurrence of KOA; progression(), no progre
n, number of subjects.
*P < 0.05, **P < 0.01, ***P < 0.001.BP, and serum HDL-cho levels were signiﬁcantly associated with
KOA occurrence after adjustment for various risk factors. However,
Model 3, incorporatingmutual adjustment for eachMS component,
indicated that only BMI was signiﬁcantly associated with KOA
occurrence. The three types of multivariate logistic regression
analyses using KOA progression as the objective factor showed
similar results as for KOA occurrence described above.
Table IV shows associations between KOA occurrence and MS
risk factors. Both Models 1 and 2 revealed that OW, HT, and IGT
were signiﬁcantly associated with KOA. Analysis using OW, HT,
DL, and IGT as explanatory variables with mutual adjustment
(Model 3) indicated that HT and IGT were signiﬁcantly associated
with KOA. Table IV also shows associations between KOA
progression and MS risk factors, indicating that OW and HT were
signiﬁcantly associated with KOA progression. Although IGT was
signiﬁcantly associated with KOA progression after adjustment
for age and gender, the effect diminished after adjustment for
various other risk factors.
KOA occurrence and progression and the number of MS components
Figure 2 shows the cumulative KOA incidence (%/year) classiﬁed
by the number of MS components present. In the total population,
the cumulative incidence classiﬁed by the number of MSof KOA
Women
KOA (þ) P KOA () KOA (þ) P
(n ¼ 18) (n ¼ 385) (n ¼ 53)
0 (0.0) 0.009 28 0 (0.0) <0.001
0 (0.0) 82 1 (0.4)
0 (0.0) 124 15 (3.6)
11 (4.2) 101 16 (4.6)
6 (2.9) 46 17 (9.0)
1 (2.8) 4 4 (16.7)
) 70.0 (6.1) 0.0021 56.4 (11.4) 66.4 (8.7) <0.0001
24.2 (3.1) 0.1709 21.9 (3.1) 23.4 (2.8) 0.0012
) 143.4 (17.7) 0.0255 127.0 (20.0) 136.5 (19.4) 0.0014
) 76.7 (10.7) 0.7907 72.0 (10.2) 73.2 (11.0) 0.4544
) 54.6 (15.7) 0.5017 67.7 (15.8) 60.8 (12.1) 0.0021
) 5.09 (0.75) 0.4644 5.01 (0.46) 5.39 (0.80) <0.0001
Women
() Progression (þ) P Progression () Progression (þ) P
(n ¼ 86) (n ¼ 626) (n ¼ 255)
1 (3.3) <0.001*** 28 1 (1.1) <0.001***
2 (1.7) 90 5 (1.8)
8 (2.8) 159 36 (6.2)
26 (6.8) 191 79 (9.8)
38 (8.9) 136 77 (12.1)
11 (13.1) 22 27 (18.4)
) 70.0 (9.4) <0.0001*** 60.7 (11.9) 68.2 (9.3) <0.0001***
23.9 (3.1) 0.0643 22.4 (3.3) 23.5 (3.1) <0.0001***
) 138.6 (17.0) 0.1390 130.4 (20.9) 137.6 (20.1) <0.0001***
) 76.3 (10.6) 0.5698 72.3 (10.5) 73.8 (12.2) 0.0792
) 53.5 (15.2) 0.0921 65.4 (15.8) 61.1 (12.6) 0.0003***
) 5.30 (0.88) 0.3687 5.11 (0.64) 5.25 (0.68) 0.0069**
ssion of the KL grade; progression(þ), progression of the KL grade.
Table III
ORs for occurrence and progression of KOA during the 3-year follow-up period vs BMI, systolic and diastolic BP, serum levels of HDL-cho, and HbA1c level
Explanatory variables Reference Model 1* Model 2y Model 3z
Adjusted OR1 95% CI P Adjusted OR2 95% CI P Adjusted OR3 95% CI P
Occurrence of KOA
BMI (kg/m2) þ1 kg/m2 1.22 1.12e1.33 <0.001*** 1.22 1.12e1.34 <0.001*** 1.18 1.07e1.30 0.001**
Systolic BP (mm Hg) þ1 mm Hg 1.54 0.87e2.72 0.136 1.01 1.00e1.03 0.038* 1.01 1.00e1.03 0.188
Diastolic BP (mm Hg) þ1 mm Hg 1.51 0.71e3.19 0.282 1.01 0.99e1.04 0.373 e e e
Serum levels of HDL-cho (mg/dL) þ1 mg/dL 0.980 0.962e0.999 0.039* 0.980 0.960e0.999 0.039* 0.989 0.968e1.009 0.256
Serum levels of HbA1c (%) þ1% 1.29 0.92e1.81 0.136 1.34 0.96e1.88 0.089 1.07 0.73e1.56 0.743
Progression of KOA
BMI (kg/m2) þ1 kg/m2 1.12 1.08e1.17 <0.001*** 1.13 1.08e1.18 <0.001*** 1.11 1.06e1.17 <0.001***
Systolic BP (mm Hg) þ1 mm Hg 1.47 1.10e1.97 0.010* 1.01 1.00e1.01 0.039* 1.00 1.00e1.01 0.352
Diastolic BP (mm Hg) þ1 mm Hg 1.33 0.92e1.91 0.124 1.01 1.00e1.025 0.057 e e e
Serum levels of HDL-cho (mg/dL) þ1 mg/dL 0.988 0.979e0.997 0.011* 0.987 0.978e0.997 0.008** 0.992 0.983e1.002 0.137
Serum levels of HbA1c (%) þ1 % 1.11 0.94e1.33 0.227 1.11 0.93e1.32 0.277 0.99 0.81e1.19 0.881
*P < 0.05, **P < 0.01, ***P < 0.001.
* Model 1 was obtained by a series of multivariate logistic regression analyses using the occurrence or progression of KOA (over 3 years, 1: yes, 0: no) as the objective
variable and each individual explanatory variable (BMI, systolic BP, diastolic BP, serum HDL-cho, or HbA1c) after adjusting for age and gender.
y Model 2 was obtained by a series of multivariate logistic regression analyses using the occurrence or progression of KOA (over 3 years, 1: yes, 0: no) as the objective
variable and each individual explanatory variable (BMI, systolic BP, diastolic BP, serum HDL-cho, or HbA1c) after adjusting for age, gender, region (0: coastal area, 1:
mountainous area), smoking (0: ex- or non-smoker, 1: current smoker), alcohol consumption (0: ex- or non-drinker, 1: current drinker), bicycling every day (0: no, 1: yes),
regular exercise (0: no, 1: yes), and past history of knee injuries (0: no, 1: yes).
z Model 3 was obtained by multivariate logistic regression analysis using the occurrence or progression of KOA (over 3 years, 1: yes, 0: no) as the objective variable and each
individual explanatory variable (BMI, systolic BP, diastolic BP, serumHDL-cho, or HbA1c) after adjusting for age, gender, region (0: coastal area, 1: mountainous area), smoking
(0: ex- or non-smoker, 1: current smoker), alcohol consumption (0: ex- or non-drinker, 1: current drinker), bicycling every day (0: no, 1: yes), regular exercise (0: no, 1: yes),
and past history of knee injuries (0: no, 1: yes), and other potential risk factors such as BMI, systolic BP, serum levels of HDL-cho, and HbA1c levels, mutually.
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which increased with the number of MS components (P for
trend < 0.001). Figure 2(A) also shows the cumulative KOA inci-
dence according to the number of MS components by gender. The
cumulative incidence among individuals with one or more MS
components was higher in women than in men.
Figure 2 also shows KL grade progression (%/year) for either
knee classiﬁed by the number of MS components present. In the
total population, KL grade progression classiﬁed by 0, 1, 2, or 3
MS components was 4.3, 7.6, 10.8, and 11.3, respectively, whichTable IV
ORs for occurrence and progression of KOA during the 3-year follow-up period vs risk fa
Explanatory variables Reference Model 1* M
Adjusted OR1 95% CI P Ad
Occurrence of KOA
Component of MS
OW Yes vs no 2.36 1.28e4.34 0.006** 2.4
HT Yes vs no 3.02 1.47e6.23 0.003** 3.2
DL Yes vs no 1.34 0.65e2.73 0.425 1.5
IGT Yes vs no 2.42 1.37e4.27 0.002** 2.4
Progression of KOA
Component of MS
OW Yes vs no 1.76 1.30e2.38 <0.001*** 1.8
HT Yes vs no 1.75 1.26e2.42 0.001** 1.7
DL Yes vs no 1.18 0.81e1.71 0.400 1.3
IGT Yes vs no 1.42 1.04e1.94 0.029* 1.3
*P < 0.05, **P < 0.01, ***P < 0.001.
Being OW was deﬁned as BMI  25 kg/m2, HT as systolic BP  130 mm Hg and/or diastol
level  5.5%. Further, subjects being treated with medication for HT, DL, or IGT were reg
* Model 1 was obtained by a series of multivariate logistic regression analyses using
variable and each individual explanatory variable (being OW, HT, DL, or IGT) after adjus
y Model 2 was obtained by a series of multivariate logistic regression analyses using
variable and each individual explanatory variable (being OW, HT, DL, and IGT) after adjus
non-smoker, 1: current smoker), alcohol consumption (0: ex- or non-drinker, 1: current
history of knee injuries (0: no, 1: yes).
z Model 3 was obtained bymultivariate logistic regression analysis using the occurrence
OW, HT, DL, and IGT as explanatory variables, after adjusting for age, gender, region (0: co
alcohol consumption (0: ex- or non-drinker, 1: current drinker), bicycling every day (0: n
and other components of MS, mutually.signiﬁcantly increased with the number of MS components (P for
trend < 0.001). The progression among individuals with one or
more MS components was higher in women than in men
[Fig. 2(B)].
To further illustrate the effects of the number of MS components
on KOA occurrence and progression, Fig. 3 presents the results of
the multivariate logistic regression analysis models for KOA
occurrence. Model 4 used KOA occurrence or KL grade progression
as the objective variable and the number of MS components
present (OW, HT, DL, and IGT) as the explanatory variable, adjustedctors for MS
odel 2y Model 3z
justed OR2 95% CI P Adjusted OR3 95% CI P
6 1.32e4.59 0.005** 1.71 0.88e3.33 0.114
7 1.57e6.80 0.002** 2.74 1.30e5.78 0.008**
5 0.75e3.23 0.240 1.20 0.55e2.59 0.646
7 1.38e4.41 0.002** 1.94 1.05e3.59 0.033*
7 1.37e2.55 <0.001*** 1.66 1.21e2.29 0.002**
5 1.26e2.43 0.001** 1.54 1.10e2.17 0.012*
6 0.93e2.01 0.117 1.26 0.85e1.87 0.248
5 0.98e1.87 0.068 1.18 0.84e1.64 0.336
ic BP  85 mm Hg, DL as serum HDL-cho level < 40 mg/dL, and IGT as serum HbA1c
arded as having the respective disorder.
the occurrence or progression of KOA (over 3 years, 1: yes, 0: no) as the objective
ting for age and gender.
the occurrence or progression of KOA (over 3 years, 1: yes, 0: no) as the objective
ting for age, gender, region (0: coastal area, 1: mountainous area), smoking (0: ex- or
drinker), bicycling every day (0: no, 1: yes), regular exercise (0: no, 1: yes), and past
or progression of KOA (over 3 years, 1: yes, 0: no) as the objective variable and being
astal area, 1: mountainous area), smoking (0: ex- or non-smoker, 1: current smoker),
o, 1: yes), regular exercise (0: no, 1: yes), past history of knee injuries (0: no, 1: yes),
 MS, metabolic syndrome. 
*MS components consisted of obesity, hypertension, dyslipidaemia, and impaired glucose tolerance.  
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Fig. 2. Cumulative incidence (%/year) of KOA (A) and progression of the KL grade of either knee (%/year) (B) classiﬁed by the number of components of MS, including OW, HT, DL,
and IGT.
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rence were found to signiﬁcantly increase with the number of MS
components present (OR, 95% CI vs no component: one component,
2.16, 0.90e5.20, P ¼ 0.085; two components, 2.49, 0.95e6.55,
P ¼ 0.063; three components, 8.38, 3.12e22.5, P < 0.001). Simi-
larly, KOA progression signiﬁcantly increased with the number of
MS components present (OR, 95% CI vs no component: one
















:p < 0.05 :p < 0.001
 Multivariate logistic regression analysis using the occurrence or pro
 variable and the number of MS components as the explanatory var
 mountainous area), smoking (0: ex- or non-smoker, 1: current smok
 drinker), bicycling every day (0: no, 1: yes), regular exercise (0: no,
POccurrence of knee osteoarthritis 
Number of components of metabolic
 syndrome 
1
Fig. 3. ORs for occurrence and progression of KOA during the 3-1.47e3.46, P < 0.001; three components: 2.59, 1.57e4.27,
P < 0.001).
Logistic regression model results obtained using KOA occur-
rence or progression as the objective variable and the number of
MS components present as explanatory variables, after adjusting
for age, gender, and the other potential risk factors listed in the
Methods section, are shown in Fig. 3. The OR signiﬁcantly increased
with the number of MS components present after adjustment forNumber of components of metabolic
 syndrome 
atio 
0         1          2        3 
gression of KOA (over 3 years, 1: yes, 0: no) as the objective
iable, after adjusting for age, gender, region (0: coastal area, 1:
er), alcohol consumption (0: ex- or non-drinker, 1: curre nt
 1: yes), and past history of knee injuries (0: no, 1: yes).  
rogression of knee osteoarthritis 
year follow-up period vs the number of risk factors for MS.
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2.33, 0.96e5.65, P ¼ 0.065; two components, 2.82, 1.05e7.54,
P ¼ 0.039; three components, 9.83, 3.57e27.1, P < 0.001). Simi-
larly, KOA progression signiﬁcantly increased with the number of
MS components present after adjustment for other risk factors (OR,
95% CI vs no component: one component, 1.38, 0.91e2.08,
P ¼ 0.126; two components, 2.29, 1.49e3.54, P < 0.001; three
components: 2.80, 1.68e4.68, P< 0.001). In bothmodels, the OR for
KOA occurrence signiﬁcantly increased with the number of MS
components present. Similar trends were observed for KOA
progression with both models.
Discussion
In this study, we determined the cumulative incidence and
progression rate of KOA diagnosed using the KL scale. We demon-
strated that KOA occurrence and progression are associated with
higher systolic BP, lower serum HDL-cho levels, and higher serum
HbA1c levels, as well as higher BMI. Incorporating mutual adjust-
ment for each MS component indicated that only BMI was signiﬁ-
cantly associated with KOA occurrence and progression. Regarding
the risk factors for MS and KOA, even after adjusting for potential
risk factors, multivariate analysis determined that HT and IGT were
signiﬁcantly associated with KOA occurrence, and OWand HT were
signiﬁcantly associated with KOA progression. The presence of
a greater number of MS components was associated with a higher
rate of KOA occurrence and progression. This tendency was much
more pronounced in occurrence of KOA than in progression.
Numerous reports have presented an association between being
OW or obese and KOA1,7e12. Lohmander et al. reported that being
OW was associated with higher KOA incidence, and among
measures of excess weight, BMI was observed to have the strongest
relative risk gradient28. In the present study, we conﬁrmed that BMI
was the only continuous value signiﬁcantly associated with KOA
occurrence and progression among the MS risk factors (e.g., BMI,
systolic BP, and serum levels of HDL-cho and HbA1c), consistent
with previous studies. In contrast, several reports have shown that
HT is associated with KOA presence, independent of OW20,29e31. In
the present study, we conﬁrmed a signiﬁcant association between
HT and IGT and KOA occurrence, and between OW and HT and KOA
progression. Although several studies have found that obesity or
increased BMI were risk factors for KOA onset32e35, this appears to
be the ﬁrst report of associations between MS risk factors other
than OW and KOA occurrence and progression.
There were differences between the results for continuous
variables such as BMI, BP, and serumHDL-cho and HbA1c levels and
those for categorical clinical criteria such as OW, HT, DL, and IGT. In
analysis involving continuous variables, BMI was the only predictor
of future KOA occurrence or progression. In contrast, clinical
criteria-based analysis clearly showed associations between
metabolic risk factors other than OW and KOA. This discrepancy
suggests that the clinical criterion for OW (BMI 25 kg/m2) may be
less sensitive than continuous BMI values in reﬂecting the associ-
ation of excess weight with KOA. We then performed additional
analyses using KOA occurrence or progression as the objective
variable and categorical risk factors for MS, such as HT, DL, and IGT,
as explanatory variables. We also added continuous values for BMI
at baseline rather than OW, after adjusting for multiple risk factors
as listed for Model 2. The resulting overall ORs for HT, DL, and IGT
adjusted for BMI on KOA occurrence or progression became smaller
than those adjusted for OW. However, the association between HT
and KOA occurrence remained signiﬁcant (OR, 2.43; 95% CI,
1.14e5.18; P ¼ 0.021), while IGT was no longer signiﬁcant (OR, 1.70;
95% CI, 0.91e3.19; P¼ 0.096). Similarly, the association between HT
and KOA progression remained signiﬁcant (OR, 1.41; 95% CI,1.00e2.00; P ¼ 0.049). These results indicate that, even if associa-
tions between KOA and categorical MS components other than BMI
are weak, if adjustments are made for OW using clinical criteria,
then HTand IGTmay be risk factors for KOA occurrence and HTmay
be a risk factor for KOA progression.
Regarding ethnic differences in KOA, we previously reported
that KOA prevalence and incidence in the original ROAD study of
3,040 baseline participants was higher than those of Cauca-
sians36,37. In contrast, with regard to ethnic differences in MS,
Hoang et al. reviewed epidemiological studies and reported that MS
prevalence in East Asians was lower than that in Caucasians38. MS
prevalence in Asia may be increasing rapidly, as Nestel et al. re-
ported a substantial increase in a cohort from Beijing from 9% in
1992 to 21% in 200239. These ethnic differences have been sug-
gested as resulting from genetic factors that modulate the associ-
ation between KOA and obesity40,41.
Regarding associations between risk factors of MS and KOA, Hart
et al. attributed the effect of excess endogenous oestrogens to
aromatization of oestrone in fat tissue20. Sowers et al. suggested
that leptin and adiponectin levels inﬂuenced OA development29.
Another hypothesis suggests that in obese subjects, metabolic
changes in the striated muscles induced by interactions between
insulin resistance and systemic inﬂammation may lead to fatigue
and muscle weakness, inﬂuencing the balance between damage
and repair mechanisms and ultimately leading to OA42,43. Inﬂam-
matory factors are suggested to be associated with both obesity and
KOA44,45. Findlay evaluated the concept that vascular pathology
might play a role in the initiation and/or progression of OA46 and
proposed that peripheral reduced blood ﬂow associated with HT
caused subchondral ischaemia. This ischaemia may in turn
compromise nutrient and gas exchange into the articular cartilage
and contribute to apoptosis of regional osteocytes of the sub-
chondral bone. Furthermore, chondrocytes of OA exposed to high
glucose concentrations exhibit impaired glucose transporter-1
downregulation47. Thus, impaired glucose transporter-1 down-
regulation may constitute an important pathogenic mechanism by
which conditions characterized by hyperglycaemia may promote
degenerative changes in chondrocytes, facilitating OA progression.
However, in the present study, after adjustment for BMI, the effect
of IGT was weak. Further studies are required to conﬁrm whether
IGT is a risk factor for KOA occurrence. Furthermore, because the
present study aimed to identify associations between metabolic
risk factors and future KOA occurrence or progression, we did not
evaluate the effects of genetic factors and other risk factors
potentially inﬂuencing MS and KOA. However, additional risk
factors for both conditions should be addressed in further analysis
of the ROAD study.
No previous studies have been performed on metabolic risk
factor clustering and KOA occurrence or progression, although
some cross-sectional epidemiological studies have evaluated the
association between metabolic risk factor clustering and KOA
presence29,31. In the present study, we demonstrated that KOA
occurrence and progression are inﬂuenced not only by individual
MS components but also by their clustering. An increase in the
number of MS components signiﬁcantly increases the risk of both
KOA occurrence and progression. This effect of clustering was
stronger for KOA occurrence than for KOA progression. Combining
the present results with those of our previous report using the
same analytical methods and adjustment factors21, the ORs for
three components vs no components were 9.95, 2.79, and 2.72 for
KOA occurrence, progression, and presence, respectively. Thus,
preventing MS would aid in reducing every stage of KOA, including
onset, worsening, and presence.
This study has several limitations. First, although it includes
a relatively large number of participants, these participants do not
N. Yoshimura et al. / Osteoarthritis and Cartilage 20 (2012) 1217e12261224represent the entire general population because they were
recruited from only two areas. Regarding potential selection bias
of the ROAD study, we previously reported that no signiﬁcant
differences were identiﬁed between our participants and the
general Japanese population, except that male participants aged
70e74 years in the ROAD study were signiﬁcantly smaller in
terms of body structure than the overall Japanese population
(P < 0.05)23. Although we could locate and include baseline
participants after 3 years with a high participation rate, this
selection bias at baseline should be considered when generalising
the results. Second, the deﬁnitions used for MS components were
not completely identical to international criteria such as the
National Cholesterol Education Program (NCEP) Adult Treatment
Panel (ATP) III, World Health Organization (WHO), or The Amer-
ican Association of Clinical Endocrinologists (AACE)48. As there
has been considerable debate regarding abdominal circumference
(85 cm in men, 90 cm in women) in the Japanese criteria49, we
decided to utilize BMI  25 kg/m2 to indicate OW rather than
abdominal circumference. Furthermore, because not all blood
samples were obtained under fasting conditions, we did not use
blood glucose and serum TG levels as indicators. Therefore, our
results may underestimate the presence of MS components,
especially DL and IGT. However, we used the alternative index for
each condition, recommended by the National Health and
Nutrition Survey for cases where collecting samples under fasting
conditions is difﬁcult26, and thus our criteria likely reﬂect
dysfunction in lipid and glucose metabolism. Finally, we used KL
grade  2 for diagnosing KOA. However, the KL scale is a cate-
gorical index, and it is impossible to evaluate the minimum joint
space and osteophytosis separately. To evaluate KOA severity
using quantitative parameters, a KOA computer-assisted diag-
nostic system50 measuring minimum joint space width and
osteophytosis area is under development; this system will
provide increased accuracy in determining the association
between MS components and KOA development for early
prevention of disability.
In conclusion, this study revealed that HT and IGT inﬂuence KOA
occurrence and that OW and HT are associated with KOA progres-
sion. KOA occurred or worsened more frequently with increase in
the number of MS components. Preventing MS may be useful in
preventing both KOA occurrence and progression.
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